A. K. Rao

发表

Acquired Disorders of Platelet Function

A. Rao, A. K. Rao, A. Rao, 2013 .

CHAPTER 58 – Acquired Disorders of Platelet Function

A. Rao, A. K. Rao, A. K. Rao, 2007 .

Blood Platelets and von Willebrand Disease

A. Rao, Jonathan L Miller, A. K. Rao, 2011 .

Impaired platelet aggregation and abnormal activation of GPIIb-IIIa.

J. Gabbeta, A. K. Rao, 1997, Thrombosis and haemostasis.

Contribution of thrombogenic factors to the pathogenesis of atherosclerosis.

S. Niewiarowski, A. Rao, A. K. Rao, 1983, Progress in cardiovascular diseases.

Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation.

B. Setty, A. Rao, M. Stuart, 2000, Blood.

The hemostatic system in children undergoing intensive plasma exchange.

P. Walsh, L. Brown, W. Grover, 1982, The Journal of pediatrics.

Congenital disorders of platelet function.

H. Holmsen, A. Rao, Rao Ak, 1986, Seminars in hematology.

Simultaneous Occurrence of Human Antibodies Directed against Fibrinogen, Thrombin, and Factor V Following Exposure to Bovine Thrombin: Effects on Blood Coagulation, Protein C Activation and Platelet Function

J. Weisel, C. Nagaswami, A. Rao, 1997, Thrombosis and Haemostasis.

Congenital Disorders of Platelet Signal Transduction and Secretion

A. K. Rao, A. K. Rao, 1999 .

Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.

A. Rao, S. Ghosh, A. K. Rao, 1993, Thrombosis research.

Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.

J. Disa, A. Rao, X. Yang, 1990, Thrombosis research.

Platelet function during cardiac operation: comparison of membrane and bubble oxygenators.

R. Colman, L. Edmunds, V. Addonizio, 1982, The Journal of thoracic and cardiovascular surgery.

Molecular Mechanisms of Platelet Activation and Inhibition

A. Rao, A. K. Rao, 1999 .

The effect of ionic and nonionic contrast media on the sickling phenomenon.

R. Steiner, S. Ballas, V. Rao, 1982, Radiology.

Lineage-specific defect in gene expression in human platelet phospholipase C-beta2 deficiency.

S. Kunapuli, A. Rao, G. Mao, 2002, Blood.

Evaluation of platelet function.

A. Rao, H. Day, A. K. Rao, 1986, Seminars in hematology.

Platelet activation with combination of ionophore A23187 and a direct protein kinase C activator induces normal secretion in patients with impaired receptor mediated secretion and abnormal signal transduction.

A. Rao, L. Sun, J. Gabbeta, 1997, Thrombosis research.

Interaction of albumin, arachidonic acid and prostanoids in platelets.

A. Purdon, A. Rao, A. D. Purdon, 1989, Prostaglandins, leukotrienes, and essential fatty acids.

Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee

W. Ouwehand, A. Leavitt, S. Watson, 2005, Journal of thrombosis and haemostasis : JTH.

Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.

R. Steiner, V. Rao, A. Rao, 1985, Radiology.

Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group.

Sunil V. Rao, R. Charnigo, A. Lincoff, 2009, American heart journal.

Antithrombin III levels during heparin therapy.

S. Niewiarowski, A. Rao, H. Day, 1981, Thrombosis research.

Recombinant Hirudin for Unstable Angina Pectoris

V. Fuster, R. Califf, H. Gold, 2005 .

Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time.

J. Gaughan, A. Comerota, A. Rao, 2003, Journal of vascular surgery.

Atherosclerosis / Coronary Heart Disease Short-term Cholesterol Lowering Decreases Size and Severity of Perfusion Abnormalities by Positron Emission Tomography After Dipyridamole in Patients With Coronary Artery Disease : A Potential Noninvasive Marker of Healing Coronary Endothelium

V. Fuster, R. Califf, K. Dickstein, 2005 .

Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation

G. Boden, A. Rao, A. Rao, 2007, Current diabetes reports.

Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor‐1 in childhood obesity: evidence of a procoagulant state

J. Gunawardana, G. Foster, E. Komaroff, 2012, British journal of haematology.

Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.

G. Criner, Carla L Grabianowski, A. Rao, 2009, Thrombosis research.

Guanosine 5'-0-(3-thiotriphosphate) induced calcium release in human platelets is mediated by inositol 1,4,5-triphosphate.

J. Disa, A. Rao, X. Yang, 1992, Thrombosis research.

Phorbol 12-myristate 13-acetate (PMA) responsive sequence in Galphaq promoter during megakaryocytic differentiation. Regulation by EGR-1 and MAP kinase pathway.

D. Dhanasekaran, A. Rao, G. Jalagadugula, 2008, Thrombosis and haemostasis.

Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal

Paul J. Harrison, T. Ortel, M. Cattaneo, 2006 .

Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect.

J. Gaughan, A. Comerota, R. Harada, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Platelet Function in Hemostasis and Inherited Disorders of Platelet Number and Function

Natthapol Songdej, A. K. Rao, 2011, Concise Guide to Hematology.

Spotlight on FLI1, RUNX1, and platelet dysfunction.

A. Rao, A. K. Rao, 2013, Blood.

Transcription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events Differential Effects of RUNX1 Variants

D. Voora, R. Myers, L. Goldfinger, 2017, Circulation.

Mechanism of Platelet Factor (PF4) Deficiency with RUNX1 Mutations: RUNX1 Is a Transcriptional Regulator of PF4.

G. Mao, G. Jalagadugula, K. Aneja, 2009 .

Acquired qualitative platelet disorders.

A. Rao, P. N. Walsh, A. K. Rao, 1983, Clinics in haematology.